These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 133299)

  • 1. Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.
    Achar VS; Welch KM; Chabi E; Bartosh K; Meyer JS
    Neurology; 1976 Aug; 26(8):777-80. PubMed ID: 133299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
    Manyam NV; Katz L; Hare TA; Gerber JC; Grossman MH
    Arch Neurol; 1980 Jun; 37(6):352-5. PubMed ID: 6446278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders.
    Enna SJ; Stern LZ; Wastek GJ; Yamamura HI
    Arch Neurol; 1977 Nov; 34(11):683-5. PubMed ID: 143928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid.
    Manyam BV; Tremblay RD
    Brain Res; 1984 Jul; 307(1-2):217-23. PubMed ID: 6235893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-aminobutyric acid (GABA) in cerebrospinal fluid.
    Kuroda H
    Acta Med Okayama; 1983 Jun; 37(3):167-77. PubMed ID: 6224397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low cerebrospinal fluid gamma-aminobutyric acid content in seizure patients.
    Wood JH; Hare TA; Glaeser BS; Ballenger JC; Post RM
    Neurology; 1979 Sep; 29(9 Pt 1):1203-8. PubMed ID: 113694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid GABA reductions in seizure patients evoked by cerebellar surface stimulation.
    Wood JH; Glaeser BS; Hare TA; Sode J; Brooks BR; Van Buren JM
    J Neurosurg; 1977 Oct; 47(4):582-9. PubMed ID: 198517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.
    Kuroda H; Ogawa N; Yamawaki Y; Nukina I; Ofuji T; Yamamoto M; Otsuki S
    J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):257-60. PubMed ID: 7086447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of gamma-aminobutyric acid in cerebrospinal fluid of dogs with epilepsy.
    Löscher W; Schwartz-Porsche D
    J Neurochem; 1986 Apr; 46(4):1322-5. PubMed ID: 3081688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA levels in cerebrospinal fluid of patients with Huntington's chorea: a preliminary report.
    Glaeser BS; Vogel WH; Oleweiler DB; Hare TA
    Biochem Med; 1975 Apr; 12(4):380-5. PubMed ID: 126061
    [No Abstract]   [Full Text] [Related]  

  • 12. The CSF iron in patients with neurological diseases.
    Kjellin KG
    Acta Neurol Scand; 1967; 43(3):299-313. PubMed ID: 4227818
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases.
    Sundquist J; Forsling ML; Olsson JE; Akerlund M
    J Neurol Neurosurg Psychiatry; 1983 Jan; 46(1):14-7. PubMed ID: 6842195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of in vitro conditions appropriate for GABA determination in human CSF: impact of acid deproteinization and freeze/thaw.
    Ferraro TN; Manyam BV; Hare TA
    J Neurochem; 1983 Oct; 41(4):1057-64. PubMed ID: 6225837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of freezing on gamma-aminobutyric acid levels in human cerebrospinal fluid.
    Abbott RJ; Keidan J; Pye IF; Nahorski SR
    J Neurochem; 1981 Oct; 37(4):1042-4. PubMed ID: 7320717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid gamma aminobutyric acid levels in migraine.
    Welch KM; Chabi E; Bartosh K; Achar VS; Meyer JS
    Br Med J; 1975 Aug; 3(5982):516-7. PubMed ID: 1164613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of gamma-aminobutyric acid in human cerebrospinal fluid: downward revision of previous control values.
    Löscher W; Schmidt D
    Ther Drug Monit; 1984; 6(2):227-31. PubMed ID: 6740742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid "specific" proteins in various degenerative neurological diseases.
    Wikkelsø C; Blomstrand C
    Acta Neurol Scand; 1982 Aug; 66(2):199-208. PubMed ID: 6215816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verification and quantification of GABA in human cerebrospinal fluid.
    Wood JH; Glaeser BS; Enna SJ; Hare TA
    J Neurochem; 1978 Jan; 30(1):291-3. PubMed ID: 621519
    [No Abstract]   [Full Text] [Related]  

  • 20. Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.
    Manyam NV; Hare TA; Katz L; Glaeser BS
    Arch Neurol; 1978 Nov; 35(11):728-30. PubMed ID: 152621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.